Stifel Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

Stifel Financial’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-87,728	Closed	-$876K	–	3028
2019 Q2	$876K	Buy	+87,728	New	+$946K	﹤0.01%	1883
2016 Q1	–	Sell	-6,782	Closed	-$205K	–	2422
2015 Q4	$205K	Sell	6,782 -5,556	-45%	-$180K	﹤0.01%	2103
2015 Q3	$490K	Sell	12,338 -18,783	-60%	-$1.17M	﹤0.01%	1569
2015 Q2	$2.15M	Buy	+31,121	New	+$1.96M	0.01%	954

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Stifel Financial's AMAG Position: Q3 2019 in Review

Stifel Financial sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 87,728 shares — an estimated $876K sold.

Stifel Financial first reported a position in AMAG in Q2 2015 and held it in 4 quarters. The position peaked at $2.15M in Q2 2015. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Stifel Financial reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Stifel Financial sold 87,728 AMAG Pharmaceuticals shares in Q3 2019, an estimated $876K.
Stifel Financial first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 4 quarters.
Stifel Financial's AMAG Pharmaceuticals position peaked at $2.15M in Q2 2015.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.